Web News Insider
-
Dhaka Shelter Gives 85 Cancer Patients Beds, Meals and Support
Cancer survivor Albab founded a home providing meals and clean rest for underprivileged patients who cannot afford treatment or stay in overcrowded…
-
Researchers find biological clues to why colorectal cancer strikes young adults
A new cell-by-cell tumor atlas sheds light on the aggressive nature of colorectal cancer in younger populations as screening rates expand.
-
High-Yield Savings Rates Reach 4.70% on November 3
New rates up to 4.70% offer a real return on cash reserves, far outpacing the national average of 0.38% and protecting savings…
-
Study Links Louisiana Industrial Pollution to Fourfold Rise in Infant Heart Defects
New research finds babies born in high-pollution areas of southeast Louisiana face significantly higher odds of severe congenital heart defects.
-
Penn study finds patient navigators overcome hidden asthma barriers
A new trial shows trained navigators help low-income adults manage environmental and social obstacles, improving asthma control.
-
UK Mortgage Market: 2.3 Million Households Face £3,600 Annual Repayment Jump as Fixed Deals Expire
Homeowners rolling off 2022 five-year fixes confront rates above 6% while first-time buyers access a new 2.5% deposit government equity loan scheme.
-
UNICORN Trial Finds Deep Responses to Preoperative Immunotherapy
New data from Agenus’ UNICORN trial reveals that short-course neoadjuvant immunotherapy achieves pathologic complete responses in 93% of dMMR colon cancer patients,…
-
Personal Factors Driving Cancer Biomarker Decisions and Patient Outcomes
Gosselaar’s campaign highlights how personal health history and financial access shape biomarker testing choices and treatment precision.
-
RBA Hike to 4.85% Adds $107 to Monthly Mortgage Repayments for Homeowners
The fifth 2026 rate lift hits an 18-year high, intensifying pressure on 3.3 million Australian households as inflation remains stubbornly above target.
-
Generic HIV Shot Cuts Cost to $40, Unlocking Access in 120 Low-Income Countries
FDA approval of Dr. Reddy’s lenacapavir generic enables affordable, twice-yearly HIV prevention for millions in developing regions.
-
AI Paper Mills Flood Journals With Unverifiable Health Studies, Researchers Warn
Chinese software generates publishable papers in under two hours using public data, but withholds code needed for verification, overwhelming peer review.
-
Major study links moderate alcohol consumption to increased cancer risk and early death
Even one drink a day raises risk of cancer, heart disease and premature death, researchers say, challenging the idea that moderate drinking…
-
Ractigen Launches Phase II Trial for Bladder Cancer Treatment
Ractigen Therapeutics initiates Phase II clinical trial for saRNA therapy RAG-01 to treat non-muscle invasive bladder cancer in China.
-
Blood Cancer UK launches £25m appeal to double leukaemia survival rates
Scientists aim to double leukaemia survival rates using a pioneering multi-treatment clinical trial method that previously transformed prostate cancer care.
-
MIT Nanoparticle Vaccine Tuning Strengthens Immune Responses in Mice
MIT researchers use engineered M13 bacteriophage particles to create more effective cancer vaccines, potentially revolutionizing patient outcomes.
-
Affluent Investors Over 60 Face Tax Risks When Splitting Assets
Affluent retirees over 60 must navigate complex tax implications when dividing their wealth, with Roth conversions and 401(k) withdrawals posing significant financial…
-
KEYNOTE-B49 Shows Pembrolizumab Delays Progression in PD-L1-Positive Breast Cancer
New data from the phase 3 trial indicate that adding immunotherapy to chemotherapy improves progression-free survival in a specific subset of advanced…
-
Flawed Studies Prompt Hormone Therapy Caution for Breast Cancer Survivors
Recent reevaluations of past studies suggest hormone therapy may be safer for breast cancer survivors than previously thought, but doctors remain cautious.
-
Histotripsy: FDA Clears Non-Invasive Cancer Treatment, HOPE4LIVER Trial Shows Promising Results
Histotripsy, a non-invasive ultrasound therapy, is now FDA-approved for liver tumors. The HOPE4LIVER trial showed local control rates and safety profiles, but…
-
October FDA Approvals Beyond Cancer: Hives, Schizophrenia, Eye Disease, Hepatitis B and Crohn Disease
From allergy to ophthalmology, new October treatments bring first-in-class options and at-home therapies for chronic conditions and rare diseases.
-
Bacteria Pair Cleared Tumours in Mice in 2025 Study; Not Yet Tested in People
Researchers at JAIST found a soil-bacteria pairing destroys human cancer xenografts in mice regardless of immune status, though the team warns this…
-
Dendritic Cell Cancer Vaccines: One FDA Approval, Most Others Still in Trials
Only sipuleucel-T is approved for advanced prostate cancer; private clinics like Immunocine in Mexico sell personalized dendritic cell therapies still in clinical…
-
CAR-T Cell Therapy Explained: How It Works, Approved Blood Cancers, and Key Risks
An oncologist’s viral reel calls it revolutionary; here is the plain guide to the treatment, its FDA-approved uses, response data, and serious…
-
Nicole Eggert’s Cancer Bills and a Trial That Cut Financial Toxicity for Patients
Despite insurance, out-of-pocket costs and lost wages create fiscal survival challenges for patients, as seen in Nicole Eggert’s battle.
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992